Results 141 to 150 of about 25,925 (236)

A Systematic Review on Disease‐Modifying Therapies in Parkinsonian Disorders

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 357-374, August 2026.
Parkinsonian disorders, including Parkinson's disease, Lewy body dementia, multiple system atrophy, and progressive supranuclear palsy, are progressive neurodegenerative conditions with no treatment options to slow disease progression. This systematic review provides an overview of evidence of disease‐modifying therapies that have been evaluated in ...
Pepijn P.N.M. Eijsvogel   +3 more
wiley   +1 more source

Balance Disorders in Young and Middle‐Aged Adults: NHANES, 2001–2004 and 2021–2023

open access: yesThe Laryngoscope, Volume 136, Issue 8, Page 3577-3593, August 2026.
This study presents nationally‐representative estimates from two health exam surveys, NHANES 2001–2004 and 2021–2023. In the two decades between test periods, scores on the modified Romberg screening test for balance function demonstrated significantly better age‐specific performance in 2021–2023.
Howard J. Hoffman   +8 more
wiley   +1 more source

Characterization of Usage Patterns of Drugs Suspected to Cause Adverse Drug Reactions in Older Hospitalized Patients

open access: yesGeriatrics &Gerontology International, Volume 26, Issue 8, August 2026.
ABSTRACT Aim This study aimed to characterize the usage patterns of drugs suspected to cause adverse drug reactions (ADRs) in older hospitalized patients. Methods Medical records of older adults admitted to the Department of Geriatrics and Hypertension at Osaka University Hospital from September 2014 to August 2021 were reviewed.
Mizuki Katsuhisa   +9 more
wiley   +1 more source

A deeper dip? Hot‐water immersion and nocturnal blood pressure regulation

open access: yes
Experimental Physiology, EarlyView.
Brendon H. Roxburgh, Kate N. Thomas
wiley   +1 more source

Adverse outcomes between VMAT2 and anticholinergics in tardive dyskinesia: A target trial emulation

open access: yesPsychiatry and Clinical Neurosciences, Volume 80, Issue 8, Page 637-644, August 2026.
Aim Vesicular monoamine transporter 2 (VMAT2) inhibitors have been approved for the treatment of tardive dyskinesia (TD), whereas anticholinergic agents are still widely used for this condition. This study aimed to compare the risk of major clinical adverse outcomes among patients with TD treated with VMAT2 inhibitors versus anticholinergic agents ...
Tien‐Wei Hsu   +13 more
wiley   +1 more source

Elevating blood pressure in neurogenic orthostatic hypotension: Investigating the efficacy and tolerability of rebreathing therapy. [PDF]

open access: yesAuton Neurosci
Baker JR   +7 more
europepmc   +1 more source

Haemodynamic determinants of supine hypertension in patients with classical orthostatic hypotension. [PDF]

open access: yesJ Hypertens
van der Stam AH   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy